SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14699483
Source:
http://linkedlifedata.com/resource/pubmed/id/14699483
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0010346
,
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0442592
,
umls-concept:C0454788
,
umls-concept:C0596545
,
umls-concept:C0666743
,
umls-concept:C1077578
,
umls-concept:C1979963
,
umls-concept:C2003903
pubmed:issue
1
pubmed:dateCreated
2003-12-30
pubmed:abstractText
The aim of this study was to evaluate the short- and long-term safety of infliximab in patients with Crohn's disease in clinical practice.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0374630
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Gastrointestinal Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0016-5085
pubmed:author
pubmed-author:ColombelJean-FredericJF
,
pubmed-author:EganLaurence JLJ
,
pubmed-author:HarmsenW ScottWS
,
pubmed-author:LoftusEdward VEVJr
,
pubmed-author:SandbornWilliam JWJ
,
pubmed-author:SchleckCathy DCD
,
pubmed-author:TremaineWilliam JWJ
,
pubmed-author:ZinsmeisterAlan RAR
pubmed:issnType
Print
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19-31
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:14699483-Adolescent
,
pubmed-meshheading:14699483-Adult
,
pubmed-meshheading:14699483-Aged
,
pubmed-meshheading:14699483-Aged, 80 and over
,
pubmed-meshheading:14699483-Antibodies, Monoclonal
,
pubmed-meshheading:14699483-Autoimmune Diseases
,
pubmed-meshheading:14699483-Child
,
pubmed-meshheading:14699483-Child, Preschool
,
pubmed-meshheading:14699483-Crohn Disease
,
pubmed-meshheading:14699483-Female
,
pubmed-meshheading:14699483-Gastrointestinal Agents
,
pubmed-meshheading:14699483-Humans
,
pubmed-meshheading:14699483-Infection
,
pubmed-meshheading:14699483-Likelihood Functions
,
pubmed-meshheading:14699483-Lupus Vulgaris
,
pubmed-meshheading:14699483-Male
,
pubmed-meshheading:14699483-Middle Aged
,
pubmed-meshheading:14699483-Neoplasms
,
pubmed-meshheading:14699483-Retrospective Studies
,
pubmed-meshheading:14699483-Serum Sickness
pubmed:year
2004
pubmed:articleTitle
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.
pubmed:affiliation
Division of Gastroenterology, Mayo Clinic, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article